Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2019-07-01 Capital/Financing Update
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
전환가액의조정(제29회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price (Refixing) for convertible bonds (29th series) issued by HLB. This type of disclosure relates to changes in the company's capital structure and financing terms. Since it specifically details the adjustment of conversion prices and the resulting change in the number of convertible shares, it falls under the category of Capital/Financing Update.
2019-07-01 Korean
신주인수권행사가액의조정(제30회차)
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing from HLB regarding the adjustment of the exercise price of warrants (신주인수권행사가액의조정). This type of disclosure relates to changes in the company's capital structure and potential future share issuance resulting from the exercise of warrants. Under the provided categories, 'Share Issue/Capital Change' (SHA) is the most appropriate classification for adjustments to warrant exercise prices and the resulting changes in exercisable shares.
2019-07-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements (stock-backed loans) of a major shareholder (Jin Yang-gon) and related parties in HLB Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-06-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by major shareholders and their special relations, including specific transaction dates and reasons for changes (e.g., resignation of an executive). This falls under the category of Major Shareholding Notification.
2019-06-25 Korean
증권발행결과(자율공시)(제32회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB) by HLB. It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of debt/equity instruments.
2019-06-14 Korean
회사합병결정(자율공시)(종속회사의주요경영사항)
M&A Activity Classification · 100% confidence The document is a formal regulatory filing regarding a corporate merger (triangular merger) between HLB USA, Inc. and LSK BioPartners, Inc. It details the merger method, purpose, ratios, and schedule. This falls under M&A activity (mergers and acquisitions).
2019-06-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.